U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06972069) titled 'Tolerance Through Mixed Chimerism (Sip-Tego)' on April 22.
Brief Summary: This is an open-label, single-institution study to assess the safety and the efficacy of the Sip-Tego regimen for the induction of donor-specific immunologic unresponsiveness to a renal allograft. The investigators propose to treat 6 adult subjects in end-stage renal disease (ESRD) who do not demonstrate evidence of prior sensitization.
Study Start Date: May 31
Study Type: INTERVENTIONAL
Condition:
Kidney Failure
Transplant Recipient (Kidney)
Transplant Tolerance
Immunosuppresion
Immunosuppression After Kidney Transplantation
Intervention:
PROCEDURE: Comb...